Matches in SemOpenAlex for { <https://semopenalex.org/work/W1926103424> ?p ?o ?g. }
- W1926103424 endingPage "771" @default.
- W1926103424 startingPage "761" @default.
- W1926103424 abstract "IL-22, a member of the IL-10 cytokine family, has recently gained significant attention as a protective agent in murine models of diseases driven by epithelial injury. Like its biochemical and functional sibling IL-10, IL-22 elicits cellular activation primarily by engaging the STAT3 signalling pathway. Exclusively produced by leukocytes, but targeting mostly cells of epithelial origin, IL-22 has been proposed as a specialized cytokine messenger acting between leukocytic and non-leukocytic cell compartments. A lack of response in leukocytes to IL-22 mirrors tightly controlled IL-22 receptor expression and probably explains the apparent lack of instant adverse effects after systemic IL-22 administration to mice. Anti-apoptotic, pro-proliferative and pro-regenerative characteristics the major biological properties of this cytokine. Specifically, application of IL-22 is associated with tissue protection and/or regeneration in murine models of infection/microbe-driven inflammation at host/environment interfaces, ventilator-induced lung injury, pancreatitis and liver damage. Overall, preclinical studies would support therapeutic administration of seemingly well-tolerated recombinant IL-22 for treatment of an array of acute diseases manifested in epithelial tissues. However, the feasibility of prolonged administration of this cytokine is expected to be restricted by the tumourigenic potential of the IL-22/STAT3 axis. IL-22, moreover, apparently displays an inherent context-specific capacity to amplify distinct aspects of autoimmune inflammation. Here, the prospects, expectations and restrictions of IL-22 administration in tissue-protective therapy are discussed." @default.
- W1926103424 created "2016-06-24" @default.
- W1926103424 creator A5052403251 @default.
- W1926103424 creator A5054077321 @default.
- W1926103424 creator A5060883328 @default.
- W1926103424 creator A5070734523 @default.
- W1926103424 creator A5074909982 @default.
- W1926103424 creator A5080016791 @default.
- W1926103424 date "2013-05-27" @default.
- W1926103424 modified "2023-10-01" @default.
- W1926103424 title "IL-22 in tissue-protective therapy" @default.
- W1926103424 cites W1497891912 @default.
- W1926103424 cites W1507781793 @default.
- W1926103424 cites W1508191015 @default.
- W1926103424 cites W1526574246 @default.
- W1926103424 cites W1528655155 @default.
- W1926103424 cites W1532206496 @default.
- W1926103424 cites W1533300579 @default.
- W1926103424 cites W1535831265 @default.
- W1926103424 cites W1548131859 @default.
- W1926103424 cites W1562760527 @default.
- W1926103424 cites W1576903429 @default.
- W1926103424 cites W1579108180 @default.
- W1926103424 cites W1775787040 @default.
- W1926103424 cites W1938903801 @default.
- W1926103424 cites W1964052073 @default.
- W1926103424 cites W1964704428 @default.
- W1926103424 cites W1969179779 @default.
- W1926103424 cites W1969366172 @default.
- W1926103424 cites W1972140301 @default.
- W1926103424 cites W1972545210 @default.
- W1926103424 cites W1973649260 @default.
- W1926103424 cites W1976790296 @default.
- W1926103424 cites W1979058179 @default.
- W1926103424 cites W1981098031 @default.
- W1926103424 cites W1981177186 @default.
- W1926103424 cites W1982229304 @default.
- W1926103424 cites W1989286818 @default.
- W1926103424 cites W1991013609 @default.
- W1926103424 cites W1993273784 @default.
- W1926103424 cites W1993763272 @default.
- W1926103424 cites W1997959054 @default.
- W1926103424 cites W1999795586 @default.
- W1926103424 cites W2002576510 @default.
- W1926103424 cites W2002602416 @default.
- W1926103424 cites W2003079717 @default.
- W1926103424 cites W2004650652 @default.
- W1926103424 cites W2005119615 @default.
- W1926103424 cites W2005359518 @default.
- W1926103424 cites W2007121925 @default.
- W1926103424 cites W2011470017 @default.
- W1926103424 cites W2012555541 @default.
- W1926103424 cites W2013242290 @default.
- W1926103424 cites W2015368628 @default.
- W1926103424 cites W2016320681 @default.
- W1926103424 cites W2017354770 @default.
- W1926103424 cites W2017570806 @default.
- W1926103424 cites W2020003175 @default.
- W1926103424 cites W2020238484 @default.
- W1926103424 cites W2020893478 @default.
- W1926103424 cites W2022971232 @default.
- W1926103424 cites W2023929840 @default.
- W1926103424 cites W2024490058 @default.
- W1926103424 cites W2024502371 @default.
- W1926103424 cites W2027926750 @default.
- W1926103424 cites W2027997166 @default.
- W1926103424 cites W2030441110 @default.
- W1926103424 cites W2031579881 @default.
- W1926103424 cites W2038131331 @default.
- W1926103424 cites W2040297369 @default.
- W1926103424 cites W2044227662 @default.
- W1926103424 cites W2045134338 @default.
- W1926103424 cites W2046549492 @default.
- W1926103424 cites W2051014917 @default.
- W1926103424 cites W2055039856 @default.
- W1926103424 cites W2055408610 @default.
- W1926103424 cites W2055912677 @default.
- W1926103424 cites W2056465423 @default.
- W1926103424 cites W2057142712 @default.
- W1926103424 cites W2062564526 @default.
- W1926103424 cites W2063557216 @default.
- W1926103424 cites W2064932444 @default.
- W1926103424 cites W2065336530 @default.
- W1926103424 cites W2067353642 @default.
- W1926103424 cites W2068162195 @default.
- W1926103424 cites W2074889887 @default.
- W1926103424 cites W2077719208 @default.
- W1926103424 cites W2079180304 @default.
- W1926103424 cites W2079241145 @default.
- W1926103424 cites W2082159115 @default.
- W1926103424 cites W2082450021 @default.
- W1926103424 cites W2084119784 @default.
- W1926103424 cites W2084196437 @default.
- W1926103424 cites W2084540950 @default.
- W1926103424 cites W2085977010 @default.
- W1926103424 cites W2089934673 @default.
- W1926103424 cites W2091845172 @default.
- W1926103424 cites W2094438002 @default.